Improved virus detection with ClamAV 0.94

Sep 04, 2008

The latest version of the open source anti-virus scanner, ClamAV 0.94, promises to improve virus detection rates with enhanced scanning capabilities.

The new version has a Disassembly Engine which will examine complex virus codes and help detect encrypted malware. Also, logical signatures are now supported by the Enhanced Detection Engine (EDE). This allows the signature database to contain variations of other signatures, enabling flexible matching of complex malware with combinations of AND, OR, and NOT.

New in version 0.94 is the Data Loss Prevention module (DLP), which scans incoming and outgoing mails for social security and credit card numbers, which alerts the user to the threat of identity theft. ClamAV 0.94 is licensed under the GPL and is available for download at the ClamAV website.

Related content

  • KlamAV

    Linux may not be as virus-ready as Windows, but who wants to harbor pointless malware? Now you can hunt for viruses with KDE's KlamAV, a desktop front-end for the ClamAV Open Source virus protection system.

  • Security Lessons: ClamAV

    Protecting Windows clients from the big bad Internet.

  • Stopgap: ClamAV 0.94.1 Fixes Errors

    Free antivirus toolkit ClamAV released a stopgap version 0.94.1 to fix a number of bugs, but also to provide a new feature.

  • Samba Antivirus

    Realtime virus scanning at the file server is an elegant and efficient option for protecting Windows clients. We’ll show you some tools and techniques for realtime scanning with Samba.

  • Citadel 7.5 Groupware Provides ClamAV Integration

    The Citadel project has released version 7.5 of its GPL3-licensed groupware server. The release improves the web interface and countless other details.

comments powered by Disqus
Subscribe to our Linux Newsletters
Find Linux and Open Source Jobs
Subscribe to our ADMIN Newsletters

Support Our Work

Linux Magazine content is made possible with support from readers like you. Please consider contributing when you’ve found an article to be beneficial.

Learn More